A study to compare the effect of HYDRASTININUM MURIATICUM and HOMOEOPATHIC CONSTITUTIONAL MEDICINE on improving quality of life of patients with UTERINE FIBROID

Effect of HYDRASTININUM MURIATICUM and HOMOEOPATHIC CONSTITUTIONAL MEDICINE on improving the quality of life of patients with LEIOMYOMA - a quasi experimental study - NIL

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/11/059969

Enrollment

Registered

2023-11-17

Start date

Unknown

Completion date

Unknown

Last updated

2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D25- Leiomyoma of uterus

Interventions

Intervention1: Hydrastininum muriaticum: Various appropriate potencies including 6c,12c,30c,200c Control Intervention1: Homoeopathic constitutional medicine: Homoeopathic constitutional medicine selec

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with signs and symptoms of Uterine fibroid 2.Patients of uterine fibroid with USG findings. 3.Women of age 20-50 years 4.Fibroid size upto 7cm

Exclusion criteria

Exclusion criteria: 1.Pregnant and lactating women 2.Hb 3.Complications of fibroid like torsion (immediate surgical management) 4.Patients with adenomyosis, ovarian tumors and uterine cysts. 5.Extra- uterine fibroid, polyp, cervical fibroid and any fibroid causing hydronephrosis 6.Malignancy of genitourinary tract or history of any malignancy

Design outcomes

Primary

Measure	Time frame
Treatment assessed by The Uterine Fibroid Symptoms and Quality of Life (UFS-QOL) questionnaireTimepoint: Each case will be reviewed at 14-21 days interval and will be followed up to a period of maximum 1 year	—

Secondary

Measure	Time frame
comparison of quality of life in patients receiving homoeopathic constitutional medicine and Hydrastininum muriaticum in various potenciesTimepoint: 1 year	—

Countries

India

Contacts

Public ContactDr DILNA KP

Kerala university of health science

drjayakishan@gmail.com9446529775

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026